Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

IBL dsDNA Ab RIA assay

Products are for professional/laboratory use only.

IBL dsDNA antibody RIA is available exclusively from Abacus dx.

The FARR assay remains a standard for serological diagnosis and management of SLE (ACR criteria):

  • FARR RIA offers a high level of diagnostic performance (specificity/ sensitivity) for SLE
  • dsDNA antibody titer detected by Farr RIA has a high correlation with disease activity
  • FARR RIA is used for the identification of patients with SLE and monitoring of therapy and development of disease.

Find out more about IBL dsDNA

View Brochure >

Assay Features

  • Radio immunoassay (100 determinations)
  • Calibrated against international standard Wo/80
  • Quantitative result evaluation (standards A – F; cut-off: 7 IU/mL)
  • Kit controls included
  • High diagnostic sensitivity and specificity
  • Total assay time less than 2 hours
  • Extended shelf life of 12 weeks
  • Excellent correlation with Amerlex/Trinity Farr RIA

 


Ordering Details

IBL dsDNA Ab RIA assay – IBRE19011

Interested in running IBL dsDNA in your laboratory?

Contact Us Now >

 



Request a Quote

Request Quote

Recent Posts

UTAK – Blank Matrices

Start with the Right Matrix: UTAK Blank Matrices When developing in-house quality controls or specialised assays, the right matrix matters. UTAK offers high-quality 100% REALâ„¢…

Read full article

IDS – Supporting Bone Research with Trusted Turnover Markers

Robust Tools for Bone & Musculoskeletal Research Understanding bone and musculoskeletal health requires tools that researchers can trust — not just today, but across years…

Read full article

Improve confidence in your Mass Spec results with Reigncom

Reigncom mass spectrometry kits are fit‑for‑purpose solutions designed to deliver method stability, consistency, and confidence across routine and specialised MS applications. Built to accelerate method…

Read full article